nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ORM1—Vandetanib—thyroid cancer	0.319	0.406	CbGbCtD
Pethidine—ALB—Vandetanib—thyroid cancer	0.134	0.171	CbGbCtD
Pethidine—CYP2B6—Sorafenib—thyroid cancer	0.0825	0.105	CbGbCtD
Pethidine—CYP2C19—Sorafenib—thyroid cancer	0.0524	0.0668	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—thyroid cancer	0.05	0.0638	CbGbCtD
Pethidine—CYP3A4—Vandetanib—thyroid cancer	0.042	0.0536	CbGbCtD
Pethidine—CYP2D6—Sorafenib—thyroid cancer	0.0398	0.0508	CbGbCtD
Pethidine—CYP3A4—Sorafenib—thyroid cancer	0.0253	0.0323	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—thyroid cancer	0.0242	0.0308	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—thyroid cancer	0.0154	0.0196	CbGbCtD
Pethidine—Anuria—Vandetanib—thyroid cancer	0.0109	0.0842	CcSEcCtD
Pethidine—Respiratory arrest—Vandetanib—thyroid cancer	0.00866	0.0669	CcSEcCtD
Pethidine—Depressed level of consciousness—Vandetanib—thyroid cancer	0.00368	0.0284	CcSEcCtD
Pethidine—Anuria—Epirubicin—thyroid cancer	0.00272	0.021	CcSEcCtD
Pethidine—Cardiac arrest—Vandetanib—thyroid cancer	0.00263	0.0203	CcSEcCtD
Pethidine—Anuria—Doxorubicin—thyroid cancer	0.00252	0.0194	CcSEcCtD
Pethidine—Neurotoxicity—Epirubicin—thyroid cancer	0.00245	0.0189	CcSEcCtD
Pethidine—Neurotoxicity—Doxorubicin—thyroid cancer	0.00227	0.0175	CcSEcCtD
Pethidine—Bradycardia—Vandetanib—thyroid cancer	0.00195	0.015	CcSEcCtD
Pethidine—Visual impairment—Vandetanib—thyroid cancer	0.00184	0.0142	CcSEcCtD
Pethidine—Mood swings—Sorafenib—thyroid cancer	0.00177	0.0136	CcSEcCtD
Pethidine—Muscle spasms—Vandetanib—thyroid cancer	0.0016	0.0124	CcSEcCtD
Pethidine—Tremor—Vandetanib—thyroid cancer	0.00156	0.012	CcSEcCtD
Pethidine—Loss of consciousness—Vandetanib—thyroid cancer	0.00146	0.0113	CcSEcCtD
Pethidine—Convulsion—Vandetanib—thyroid cancer	0.00144	0.0111	CcSEcCtD
Pethidine—Hypertension—Vandetanib—thyroid cancer	0.00144	0.0111	CcSEcCtD
Pethidine—Anxiety—Vandetanib—thyroid cancer	0.00141	0.0109	CcSEcCtD
Pethidine—Dry mouth—Vandetanib—thyroid cancer	0.00139	0.0107	CcSEcCtD
Pethidine—Paralysis—Epirubicin—thyroid cancer	0.00137	0.0106	CcSEcCtD
Pethidine—Oedema—Vandetanib—thyroid cancer	0.00136	0.0105	CcSEcCtD
Pethidine—Paralysis—Doxorubicin—thyroid cancer	0.00127	0.00976	CcSEcCtD
Pethidine—Insomnia—Vandetanib—thyroid cancer	0.00123	0.00949	CcSEcCtD
Pethidine—Flushing—Sorafenib—thyroid cancer	0.0012	0.00925	CcSEcCtD
Pethidine—Decreased appetite—Vandetanib—thyroid cancer	0.00118	0.00912	CcSEcCtD
Pethidine—Injection site pain—Epirubicin—thyroid cancer	0.00116	0.00898	CcSEcCtD
Pethidine—Constipation—Vandetanib—thyroid cancer	0.00116	0.00897	CcSEcCtD
Pethidine—Erythema—Sorafenib—thyroid cancer	0.00112	0.00867	CcSEcCtD
Pethidine—Delirium—Epirubicin—thyroid cancer	0.0011	0.00852	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—thyroid cancer	0.00108	0.00834	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—thyroid cancer	0.00108	0.00834	CcSEcCtD
Pethidine—Muscle spasms—Sorafenib—thyroid cancer	0.00108	0.00834	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—thyroid cancer	0.00108	0.00831	CcSEcCtD
Pethidine—Delirium—Doxorubicin—thyroid cancer	0.00102	0.00789	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—thyroid cancer	0.00101	0.0078	CcSEcCtD
Pethidine—Syncope—Sorafenib—thyroid cancer	0.00101	0.00778	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—thyroid cancer	0.001	0.00772	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—thyroid cancer	0.001	0.00772	CcSEcCtD
Pethidine—Loss of consciousness—Sorafenib—thyroid cancer	0.000988	0.00762	CcSEcCtD
Pethidine—Asthenia—Vandetanib—thyroid cancer	0.000976	0.00753	CcSEcCtD
Pethidine—Hypertension—Sorafenib—thyroid cancer	0.00097	0.00749	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—thyroid cancer	0.000967	0.00747	CcSEcCtD
Pethidine—Pruritus—Vandetanib—thyroid cancer	0.000962	0.00742	CcSEcCtD
Pethidine—Dry mouth—Sorafenib—thyroid cancer	0.000936	0.00722	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—thyroid cancer	0.000935	0.00722	CcSEcCtD
Pethidine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000917	0.00708	CcSEcCtD
Pethidine—Shock—Sorafenib—thyroid cancer	0.000902	0.00696	CcSEcCtD
Pethidine—Dizziness—Vandetanib—thyroid cancer	0.000899	0.00694	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—thyroid cancer	0.000895	0.00691	CcSEcCtD
Pethidine—Anorexia—Sorafenib—thyroid cancer	0.000874	0.00675	CcSEcCtD
Pethidine—Coma—Epirubicin—thyroid cancer	0.000868	0.0067	CcSEcCtD
Pethidine—Vomiting—Vandetanib—thyroid cancer	0.000864	0.00667	CcSEcCtD
Pethidine—Rash—Vandetanib—thyroid cancer	0.000857	0.00662	CcSEcCtD
Pethidine—Dermatitis—Vandetanib—thyroid cancer	0.000856	0.00661	CcSEcCtD
Pethidine—Headache—Vandetanib—thyroid cancer	0.000852	0.00657	CcSEcCtD
Pethidine—Nausea—Vandetanib—thyroid cancer	0.000808	0.00623	CcSEcCtD
Pethidine—Coma—Doxorubicin—thyroid cancer	0.000803	0.0062	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—thyroid cancer	0.000801	0.00618	CcSEcCtD
Pethidine—Decreased appetite—Sorafenib—thyroid cancer	0.000797	0.00615	CcSEcCtD
Pethidine—Constipation—Sorafenib—thyroid cancer	0.000784	0.00605	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—thyroid cancer	0.000741	0.00572	CcSEcCtD
Pethidine—Urticaria—Sorafenib—thyroid cancer	0.000729	0.00562	CcSEcCtD
Pethidine—Affect lability—Epirubicin—thyroid cancer	0.000679	0.00524	CcSEcCtD
Pethidine—Hypersensitivity—Sorafenib—thyroid cancer	0.000676	0.00521	CcSEcCtD
Pethidine—Asthenia—Sorafenib—thyroid cancer	0.000658	0.00508	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—thyroid cancer	0.000656	0.00506	CcSEcCtD
Pethidine—Mood swings—Epirubicin—thyroid cancer	0.000653	0.00504	CcSEcCtD
Pethidine—Pruritus—Sorafenib—thyroid cancer	0.000649	0.00501	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00063	0.00486	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—thyroid cancer	0.000628	0.00485	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000607	0.00468	CcSEcCtD
Pethidine—Dizziness—Sorafenib—thyroid cancer	0.000607	0.00468	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—thyroid cancer	0.000605	0.00467	CcSEcCtD
Pethidine—Vomiting—Sorafenib—thyroid cancer	0.000583	0.0045	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000583	0.0045	CcSEcCtD
Pethidine—Rash—Sorafenib—thyroid cancer	0.000578	0.00446	CcSEcCtD
Pethidine—Dermatitis—Sorafenib—thyroid cancer	0.000578	0.00446	CcSEcCtD
Pethidine—Headache—Sorafenib—thyroid cancer	0.000575	0.00443	CcSEcCtD
Pethidine—Nausea—Sorafenib—thyroid cancer	0.000545	0.0042	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—thyroid cancer	0.000531	0.0041	CcSEcCtD
Pethidine—Sweating—Epirubicin—thyroid cancer	0.00051	0.00393	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—thyroid cancer	0.000492	0.00379	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—thyroid cancer	0.000486	0.00375	CcSEcCtD
Pethidine—Sweating—Doxorubicin—thyroid cancer	0.000471	0.00364	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—thyroid cancer	0.00046	0.00355	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—thyroid cancer	0.000449	0.00347	CcSEcCtD
Pethidine—Flushing—Epirubicin—thyroid cancer	0.000443	0.00342	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—thyroid cancer	0.000425	0.00328	CcSEcCtD
Pethidine—Erythema—Epirubicin—thyroid cancer	0.000415	0.00321	CcSEcCtD
Pethidine—Flushing—Doxorubicin—thyroid cancer	0.00041	0.00316	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—thyroid cancer	0.000399	0.00308	CcSEcCtD
Pethidine—Erythema—Doxorubicin—thyroid cancer	0.000384	0.00297	CcSEcCtD
Pethidine—Agitation—Epirubicin—thyroid cancer	0.000382	0.00295	CcSEcCtD
Pethidine—Vertigo—Epirubicin—thyroid cancer	0.000373	0.00288	CcSEcCtD
Pethidine—Syncope—Epirubicin—thyroid cancer	0.000372	0.00287	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—thyroid cancer	0.000369	0.00285	CcSEcCtD
Pethidine—Palpitations—Epirubicin—thyroid cancer	0.000367	0.00283	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—thyroid cancer	0.000365	0.00282	CcSEcCtD
Pethidine—Convulsion—Epirubicin—thyroid cancer	0.00036	0.00278	CcSEcCtD
Pethidine—Hypertension—Epirubicin—thyroid cancer	0.000359	0.00277	CcSEcCtD
Pethidine—Agitation—Doxorubicin—thyroid cancer	0.000353	0.00273	CcSEcCtD
Pethidine—Anxiety—Epirubicin—thyroid cancer	0.000352	0.00272	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—thyroid cancer	0.000346	0.00267	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—thyroid cancer	0.000345	0.00266	CcSEcCtD
Pethidine—Syncope—Doxorubicin—thyroid cancer	0.000345	0.00266	CcSEcCtD
Pethidine—Confusional state—Epirubicin—thyroid cancer	0.000342	0.00264	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—thyroid cancer	0.00034	0.00262	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000339	0.00262	CcSEcCtD
Pethidine—Oedema—Epirubicin—thyroid cancer	0.000339	0.00262	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000338	0.00261	CcSEcCtD
Pethidine—Shock—Epirubicin—thyroid cancer	0.000333	0.00257	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—thyroid cancer	0.000333	0.00257	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—thyroid cancer	0.000332	0.00256	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—thyroid cancer	0.000331	0.00255	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000328	0.00253	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—thyroid cancer	0.000326	0.00252	CcSEcCtD
Pethidine—Anorexia—Epirubicin—thyroid cancer	0.000323	0.00249	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—thyroid cancer	0.00032	0.00247	CcSEcCtD
Pethidine—Hypotension—Epirubicin—thyroid cancer	0.000317	0.00244	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—thyroid cancer	0.000316	0.00244	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000314	0.00242	CcSEcCtD
Pethidine—Oedema—Doxorubicin—thyroid cancer	0.000314	0.00242	CcSEcCtD
Pethidine—Shock—Doxorubicin—thyroid cancer	0.000309	0.00238	CcSEcCtD
Pethidine—Insomnia—Epirubicin—thyroid cancer	0.000307	0.00237	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—thyroid cancer	0.000306	0.00236	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000303	0.00234	CcSEcCtD
Pethidine—Somnolence—Epirubicin—thyroid cancer	0.000301	0.00233	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—thyroid cancer	0.000299	0.00231	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—thyroid cancer	0.000295	0.00227	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—thyroid cancer	0.000293	0.00226	CcSEcCtD
Pethidine—Constipation—Epirubicin—thyroid cancer	0.00029	0.00224	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—thyroid cancer	0.000284	0.00219	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—thyroid cancer	0.000279	0.00216	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—thyroid cancer	0.000279	0.00215	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—thyroid cancer	0.000273	0.0021	CcSEcCtD
Pethidine—Urticaria—Epirubicin—thyroid cancer	0.000269	0.00208	CcSEcCtD
Pethidine—Constipation—Doxorubicin—thyroid cancer	0.000268	0.00207	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000258	0.00199	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—thyroid cancer	0.00025	0.00193	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—thyroid cancer	0.000249	0.00192	CcSEcCtD
Pethidine—Asthenia—Epirubicin—thyroid cancer	0.000243	0.00188	CcSEcCtD
Pethidine—Pruritus—Epirubicin—thyroid cancer	0.00024	0.00185	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000231	0.00178	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—thyroid cancer	0.000225	0.00174	CcSEcCtD
Pethidine—Dizziness—Epirubicin—thyroid cancer	0.000224	0.00173	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—thyroid cancer	0.000222	0.00171	CcSEcCtD
Pethidine—Vomiting—Epirubicin—thyroid cancer	0.000216	0.00166	CcSEcCtD
Pethidine—GRIN1—Alzheimers Disease—TP53—thyroid cancer	0.000214	0.00249	CbGpPWpGaD
Pethidine—Rash—Epirubicin—thyroid cancer	0.000214	0.00165	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—thyroid cancer	0.000214	0.00165	CcSEcCtD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000213	0.00248	CbGpPWpGaD
Pethidine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000213	0.00248	CbGpPWpGaD
Pethidine—Headache—Epirubicin—thyroid cancer	0.000212	0.00164	CcSEcCtD
Pethidine—GRIN1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000212	0.00246	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—TSHR—thyroid cancer	0.000209	0.00243	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TP53—thyroid cancer	0.000209	0.00243	CbGpPWpGaD
Pethidine—Dizziness—Doxorubicin—thyroid cancer	0.000207	0.0016	CcSEcCtD
Pethidine—GRIN2B—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000207	0.0024	CbGpPWpGaD
Pethidine—Nausea—Epirubicin—thyroid cancer	0.000201	0.00155	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—thyroid cancer	0.000199	0.00154	CcSEcCtD
Pethidine—Rash—Doxorubicin—thyroid cancer	0.000198	0.00153	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—thyroid cancer	0.000198	0.00152	CcSEcCtD
Pethidine—Headache—Doxorubicin—thyroid cancer	0.000196	0.00152	CcSEcCtD
Pethidine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000196	0.00228	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CALCB—thyroid cancer	0.000196	0.00227	CbGpPWpGaD
Pethidine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000195	0.00226	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00019	0.00221	CbGpPWpGaD
Pethidine—Nausea—Doxorubicin—thyroid cancer	0.000186	0.00144	CcSEcCtD
Pethidine—GRIN2A—Neuronal System—BRAF—thyroid cancer	0.000186	0.00216	CbGpPWpGaD
Pethidine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000181	0.0021	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00018	0.0021	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CDK1—thyroid cancer	0.00018	0.00209	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—HRAS—thyroid cancer	0.000178	0.00207	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—PTCH1—thyroid cancer	0.000178	0.00206	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—TSHR—thyroid cancer	0.000177	0.00205	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CDK1—thyroid cancer	0.000176	0.00204	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—HRAS—thyroid cancer	0.000174	0.00202	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—RXRA—thyroid cancer	0.000167	0.00194	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—RXRA—thyroid cancer	0.000163	0.00189	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—PPARG—thyroid cancer	0.000163	0.00189	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—SST—thyroid cancer	0.000162	0.00189	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—BRAF—thyroid cancer	0.000162	0.00189	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—BRAF—thyroid cancer	0.000158	0.00184	CbGpPWpGaD
Pethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000158	0.00184	CbGpPWpGaD
Pethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000157	0.00183	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CALCA—thyroid cancer	0.000156	0.00182	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TP53—thyroid cancer	0.000155	0.00181	CbGpPWpGaD
Pethidine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000151	0.00176	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—PTCH1—thyroid cancer	0.00015	0.00174	CbGpPWpGaD
Pethidine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.00015	0.00174	CbGpPWpGaD
Pethidine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000149	0.00173	CbGpPWpGaD
Pethidine—GRIN2C—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000146	0.0017	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000146	0.00169	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000146	0.00169	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000144	0.00167	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000144	0.00167	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000143	0.00166	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—SST—thyroid cancer	0.000137	0.0016	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CALCB—thyroid cancer	0.000137	0.00159	CbGpPWpGaD
Pethidine—GRIN2D—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000136	0.00158	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000134	0.00156	CbGpPWpGaD
Pethidine—OPRM1—IL4-mediated signaling events—AKT1—thyroid cancer	0.000133	0.00155	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CALCA—thyroid cancer	0.000132	0.00154	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TRIM33—thyroid cancer	0.00013	0.00151	CbGpPWpGaD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.00013	0.00151	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000129	0.0015	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000129	0.0015	CbGpPWpGaD
Pethidine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000128	0.00149	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000127	0.00147	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—HRAS—thyroid cancer	0.000127	0.00147	CbGpPWpGaD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000126	0.00147	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—HRAS—thyroid cancer	0.000124	0.00144	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000121	0.00141	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00012	0.0014	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—TSHR—thyroid cancer	0.000118	0.00137	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CALCB—thyroid cancer	0.000116	0.00134	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000113	0.00132	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—HRAS—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—AKT1—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—HRAS—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—PTEN—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MINPP1—thyroid cancer	0.00011	0.00128	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TRIM33—thyroid cancer	0.00011	0.00127	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—AKT1—thyroid cancer	0.000109	0.00127	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000109	0.00127	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000108	0.00125	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—TSHR—thyroid cancer	0.000107	0.00125	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000107	0.00124	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—PPARG—thyroid cancer	0.000106	0.00123	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000105	0.00123	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—HRAS—thyroid cancer	0.000104	0.00121	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000104	0.00121	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—PPARG—thyroid cancer	0.000103	0.0012	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—TSHR—thyroid cancer	9.98e-05	0.00116	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—AKT1—thyroid cancer	9.87e-05	0.00115	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—HRAS—thyroid cancer	9.74e-05	0.00113	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.66e-05	0.00112	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—HRAS—thyroid cancer	9.5e-05	0.0011	CbGpPWpGaD
Pethidine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	9.36e-05	0.00109	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	9.35e-05	0.00109	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—BRAF—thyroid cancer	9.28e-05	0.00108	CbGpPWpGaD
Pethidine—ALB—Metabolism—MINPP1—thyroid cancer	9.26e-05	0.00108	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—SST—thyroid cancer	9.18e-05	0.00107	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.16e-05	0.00106	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PTCH1—thyroid cancer	9.12e-05	0.00106	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TSHR—thyroid cancer	9.06e-05	0.00105	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—NRAS—thyroid cancer	9.05e-05	0.00105	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	8.91e-05	0.00104	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CALCA—thyroid cancer	8.84e-05	0.00103	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—NRAS—thyroid cancer	8.83e-05	0.00103	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CHST14—thyroid cancer	8.79e-05	0.00102	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TCF7L1—thyroid cancer	8.65e-05	0.00101	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—HRAS—thyroid cancer	8.56e-05	0.000995	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—SST—thyroid cancer	8.34e-05	0.000969	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PRKAR1A—thyroid cancer	8.32e-05	0.000967	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MINPP1—thyroid cancer	8.31e-05	0.000966	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.11e-05	0.000943	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CALCA—thyroid cancer	8.03e-05	0.000933	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—thyroid cancer	8.02e-05	0.000932	CbGpPWpGaD
Pethidine—ALB—Metabolism—NDUFA13—thyroid cancer	7.87e-05	0.000915	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—KRAS—thyroid cancer	7.79e-05	0.000906	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—SST—thyroid cancer	7.76e-05	0.000902	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	7.7e-05	0.000895	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MINPP1—thyroid cancer	7.65e-05	0.000889	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—thyroid cancer	7.61e-05	0.000885	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—KRAS—thyroid cancer	7.6e-05	0.000883	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	7.47e-05	0.000868	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—HRAS—thyroid cancer	7.47e-05	0.000868	CbGpPWpGaD
Pethidine—ALB—Metabolism—CHST14—thyroid cancer	7.4e-05	0.00086	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	7.32e-05	0.00085	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	7.32e-05	0.00085	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	7.31e-05	0.00085	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—HRAS—thyroid cancer	7.28e-05	0.000846	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	7.26e-05	0.000844	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.2e-05	0.000837	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HPGD—thyroid cancer	7.09e-05	0.000824	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	7.07e-05	0.000822	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—SST—thyroid cancer	7.05e-05	0.000819	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.8e-05	0.000791	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	6.78e-05	0.000788	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CHST14—thyroid cancer	6.65e-05	0.000772	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—HRAS—thyroid cancer	6.62e-05	0.00077	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	6.5e-05	0.000756	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—NRAS—thyroid cancer	6.46e-05	0.000751	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—HRAS—thyroid cancer	6.46e-05	0.000751	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSHR—thyroid cancer	6.33e-05	0.000736	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—NRAS—thyroid cancer	6.3e-05	0.000732	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	6.23e-05	0.000724	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	6.14e-05	0.000714	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CHST14—thyroid cancer	6.11e-05	0.00071	CbGpPWpGaD
Pethidine—ALB—Metabolism—HPGD—thyroid cancer	5.97e-05	0.000694	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MEN1—thyroid cancer	5.95e-05	0.000692	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.57e-05	0.000647	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—KRAS—thyroid cancer	5.56e-05	0.000646	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IFNA2—thyroid cancer	5.51e-05	0.00064	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.48e-05	0.000637	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—KRAS—thyroid cancer	5.42e-05	0.00063	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	5.38e-05	0.000626	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HPGD—thyroid cancer	5.36e-05	0.000623	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSHR—thyroid cancer	5.35e-05	0.000622	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	5.27e-05	0.000612	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MEN1—thyroid cancer	5.03e-05	0.000585	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MINPP1—thyroid cancer	5e-05	0.000581	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HPGD—thyroid cancer	4.93e-05	0.000573	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SST—thyroid cancer	4.93e-05	0.000572	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.84e-05	0.000563	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CALCA—thyroid cancer	4.74e-05	0.000551	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—thyroid cancer	4.73e-05	0.000549	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—thyroid cancer	4.61e-05	0.000536	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.6e-05	0.000535	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	4.55e-05	0.000529	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.35e-05	0.000505	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDK1—thyroid cancer	4.29e-05	0.000499	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—thyroid cancer	4.27e-05	0.000496	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.25e-05	0.000494	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—AKT1—thyroid cancer	4.17e-05	0.000485	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SST—thyroid cancer	4.16e-05	0.000484	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TPR—thyroid cancer	4.07e-05	0.000473	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—AKT1—thyroid cancer	4.07e-05	0.000473	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CALCA—thyroid cancer	4.01e-05	0.000466	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	4.01e-05	0.000466	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CHST14—thyroid cancer	4e-05	0.000464	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDK1—thyroid cancer	3.63e-05	0.000422	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRG1—thyroid cancer	3.44e-05	0.0004	CbGpPWpGaD
Pethidine—ALB—Metabolism—TPR—thyroid cancer	3.43e-05	0.000398	CbGpPWpGaD
Pethidine—ALB—Metabolism—PRKAR1A—thyroid cancer	3.37e-05	0.000392	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPGD—thyroid cancer	3.22e-05	0.000374	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TERT—thyroid cancer	3.09e-05	0.000359	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TPR—thyroid cancer	3.08e-05	0.000358	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.06e-05	0.000355	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	3.05e-05	0.000354	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.03e-05	0.000352	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	2.96e-05	0.000344	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRG1—thyroid cancer	2.91e-05	0.000338	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TPR—thyroid cancer	2.83e-05	0.000329	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.78e-05	0.000324	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.74e-05	0.000319	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—thyroid cancer	2.61e-05	0.000304	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	2.61e-05	0.000303	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.57e-05	0.000299	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A5—thyroid cancer	2.57e-05	0.000298	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—RXRA—thyroid cancer	2.56e-05	0.000298	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	2.5e-05	0.000291	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—thyroid cancer	2.45e-05	0.000285	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.4e-05	0.000279	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.3e-05	0.000268	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	2.24e-05	0.000261	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	2.2e-05	0.000256	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.16e-05	0.000251	CbGpPWpGaD
Pethidine—ALB—Metabolism—RXRA—thyroid cancer	2.16e-05	0.000251	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.12e-05	0.000246	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.1e-05	0.000244	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—thyroid cancer	2.07e-05	0.000241	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—thyroid cancer	2.05e-05	0.000239	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—RXRA—thyroid cancer	1.94e-05	0.000225	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	1.91e-05	0.000222	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	1.9e-05	0.00022	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.88e-05	0.000219	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	1.85e-05	0.000215	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TPR—thyroid cancer	1.85e-05	0.000215	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.82e-05	0.000212	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.79e-05	0.000208	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.78e-05	0.000207	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—thyroid cancer	1.77e-05	0.000206	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—thyroid cancer	1.73e-05	0.000201	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	1.68e-05	0.000196	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.62e-05	0.000188	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	1.61e-05	0.000187	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—thyroid cancer	1.57e-05	0.000183	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	1.57e-05	0.000182	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—thyroid cancer	1.54e-05	0.000179	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—thyroid cancer	1.51e-05	0.000176	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—thyroid cancer	1.5e-05	0.000175	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—thyroid cancer	1.46e-05	0.000169	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	1.42e-05	0.000165	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.38e-05	0.000161	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—thyroid cancer	1.36e-05	0.000158	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—thyroid cancer	1.33e-05	0.000154	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—thyroid cancer	1.32e-05	0.000154	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—thyroid cancer	1.3e-05	0.000151	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.27e-05	0.000148	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.22e-05	0.000142	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—thyroid cancer	1.18e-05	0.000137	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.16e-05	0.000135	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—thyroid cancer	1.13e-05	0.000131	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.12e-05	0.000131	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—thyroid cancer	1.12e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—thyroid cancer	1.11e-05	0.000129	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000124	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—thyroid cancer	9.95e-06	0.000116	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—thyroid cancer	9.94e-06	0.000116	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—thyroid cancer	9.61e-06	0.000112	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—thyroid cancer	9.52e-06	0.000111	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—thyroid cancer	9.34e-06	0.000109	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—thyroid cancer	8.84e-06	0.000103	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—thyroid cancer	8.4e-06	9.77e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—thyroid cancer	8.38e-06	9.74e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—thyroid cancer	7.71e-06	8.96e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—thyroid cancer	7.35e-06	8.54e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—thyroid cancer	6.39e-06	7.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.78e-06	6.72e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—thyroid cancer	5.38e-06	6.25e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—thyroid cancer	5.04e-06	5.86e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—thyroid cancer	4.83e-06	5.61e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—thyroid cancer	4.44e-06	5.16e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.9e-06	3.38e-05	CbGpPWpGaD
